Immunology Drugs
398 FDA-approved drugs
Recent Approvals
ICOTYDE
ICOTROKINRA HYDROCHLORIDE
moderate-to-severe plaque psoriasis in adults and pediatric patients 12 years of age and older who w...
2026-03-17
Johnson & Johnson
IL-23
YARTEMLEA
NARSOPLIMAB-WUUG
adult and pediatric patients 2 years of age and older with hematopoietic stem cell transplant-associ...
2025-12-23
OMEROS CORP
RHAPSIDO
REMIBRUTINIB
chronic spontaneous urticaria (CSU) in adult patients who remain symptomatic despite H1 antihistamin...
2025-09-30
Novartis
BTK
WAYRILZ
RILZABRUTINIB
adult patients with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient...
2025-08-29
Sanofi
BTK
OTEZLA XR
APREMILAST
adult patients and pediatric patients 6 years of age and older and weighing at least 20 kg with acti...
2025-08-29
Amgen
VYSCOXA
CELECOXIB
the management of acute pain or treatment of primary dysmenorrhea...
2025-07-29
CARWIN PHARM ASSOC
ANDEMBRY
GARADACIMAB-GXII
prophylaxis to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 1...
2025-06-16
CSL Behring
STARJEMZA
USTEKINUMAB-HMNY
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2025-05-22
BIO-THERA SOLUTIONS LTD
IL-12IL-23
IMAAVY
NIPOCALIMAB-AAHU
generalized myasthenia gravis (gMG) in adult and pediatric patients 12 years of age and older who ar...
2025-04-29
Johnson & Johnson
AVTOZMA
TOCILIZUMAB-ANOH
adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate re...
2025-01-24
CELLTRION INC
IL-6
STEQEYMA
USTEKINUMAB-STBA
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-12-17
CELLTRION, INC.
IL-12IL-23
YESINTEK
USTEKINUMAB-KFCE
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-11-29
BIOCON BIOLOGICS INC
IL-12IL-23
IMULDOSA
USTEKINUMAB-SRLF
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-10-10
ACCORD BIOPHARMA INC.
IL-12IL-23
OTULFI
USTEKINUMAB-AAUZ
adults and pediatric patients 6 years of age and older with moderate to severe plaque psoriasis who ...
2024-09-27
Fresenius Kabi
IL-12IL-23
EBGLYSS
LEBRIKIZUMAB-LBKZ
adults and pediatric patients 12 years of age and older who weigh at least 40 kg with moderate-to-se...
2024-09-13
Eli Lilly
IL-13IL-4R
NIKTIMVO
axatilimab-csfr
chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic ther...
2024-08-14
INCYTE CORP
NEMLUVIO
NEMOLIZUMAB-ILTO
adults with prurigo nodularis...
2024-08-12
GALDERMA LABS LP
NEFFY
EPINEPHRINE
emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric pati...
2024-08-09
ARS PHARMS OPERATION
LEQSELVI
DEURUXOLITINIB PHOSPHATE
adult patients with severe alopecia areata...
2024-07-25
Sun Pharma
JAK1JAK2JAK3
BARICITINIB
BARICITINIB
2024-07-22
Aurobindo Pharma
Showing 20 of 398 drugs
Top Companies
Drug Classes
Nonsteroidal Anti-inflammatory Drug 14
Tumor Necrosis Factor Blocker 12
Corticosteroid 12
Interleukin-12 Antagonist 7
Complement Inhibitor 7
Calcineurin Inhibitor Immunosuppressant 7
Aminosalicylate 7
Interleukin-6 Receptor Antagonist 5
Vitamin D Analog 5
Kinase Inhibitor 4
Quick Stats
- Total Drugs
- 398
- Companies
- 174
- Drug Classes
- 50
- Latest Approval
- 2026-03-17